Active breathing control (ABC) for Hodgkin's disease: reduction in normal tissue irradiation with deep inspiration and implications for treatment.

[1]  L. Boersma,et al.  Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Hancock,et al.  Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. , 1996, Seminars in radiation oncology.

[3]  J. Wong,et al.  Potential for dose escalation in the radiotherapy of hepatic tumors using active breathing control (ABC): A planning study , 1998 .

[4]  L. Boersma,et al.  Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Coleman,et al.  Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Flavio Crippa,et al.  Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Wong,et al.  The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.

[8]  Vijayakumar,et al.  Radiation Therapy Techniques in the Treatment of Hodgkin's Disease. , 1996, Seminars in radiation oncology.

[9]  A. Hagenbeek,et al.  Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[10]  J M Balter,et al.  Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors. , 1997, International journal of radiation oncology, biology, physics.

[11]  E. Winer,et al.  Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. , 1990, International journal of radiation oncology, biology, physics.

[12]  S. Shapiro,et al.  Prospective study of long-term pulmonary manifestations of mantle irradiation. , 1990, International journal of radiation oncology, biology, physics.

[13]  R. Weichselbaum,et al.  Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Donaldson,et al.  Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. , 1989, International journal of radiation oncology, biology, physics.

[15]  E. Block,et al.  Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. , 1989, International journal of radiation oncology, biology, physics.

[16]  S L Hancock,et al.  Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.

[17]  J Wong,et al.  Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. , 1997, International journal of radiation oncology, biology, physics.

[18]  J. Cosset,et al.  Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience , 1991 .

[19]  M. Henry-Amar,et al.  Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. , 1990, Seminars in oncology.

[20]  E. Noordijk,et al.  Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. , 1990, International journal of radiation oncology, biology, physics.

[21]  G J Kutcher,et al.  Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.

[22]  S. Rosenberg,et al.  The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. , 1982, Blood.

[23]  M. Martel,et al.  Dose-volume analysis of excess cardiac irradiation associated with splenic treatment in Hodgkin's disease , 1998 .

[24]  R. Olshen,et al.  Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  T. Landberg,et al.  Original article: Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin's disease , 1992 .

[26]  B. Clarkson,et al.  Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Tubiana,et al.  Pericarditis and myocardial infarctions after Hodgkin's disease therapy. , 1991, International journal of radiation oncology, biology, physics.

[28]  S. Hancock,et al.  Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. , 1988, Annals of internal medicine.

[29]  M Goitein,et al.  The effect of the respiratory cycle on mediastinal and lung dimensions in Hodgkin's disease. Implications for radiotherapy gated to respiration , 1987, Cancer.

[30]  L. Kalish,et al.  Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. , 1995, The cancer journal from Scientific American.